Related Experiment Video
Updated: Jul 9, 2026

Real-time Analyses of Retinol Transport by the Membrane Receptor of Plasma Retinol Binding Protein
Published on: January 28, 2013
Retinol binding protein 4, low birth weight-related insulin resistance and hormonal contraception
Antonella Zugaro1, Caterina Pandolfi, Arcangelo Barbonetti
1Department of Internal Medicine and Public Health, University of L'Aquila, Coppito, 67100, L'Aquila, Italy.
Insights
Serum retinol binding protein 4 (RBP4) is not an early marker for insulin resistance in low birth weight women. However, hormonal contraception use is associated with increased RBP4 levels.
Area of Science:
- Endocrinology
- Metabolic Health
- Reproductive Health
Background:
- Retinol binding protein 4 (RBP4) is implicated as a potential early marker for insulin resistance (IR).
- Low birth weight (LBW) is associated with increased risk of early-onset IR.
- The relationship between RBP4, LBW, and IR requires further elucidation.
Purpose of the Study:
- To investigate serum RBP4 levels in young women born with LBW as a model for early-onset IR.
- To determine if LBW is associated with elevated RBP4 and reduced insulin sensitivity.
- To explore factors associated with RBP4 levels in this population.
Main Methods:
- A historical prospective study comparing 35 LBW women with 35 term appropriate for gestational age (AGA) controls.
- Metabolic evaluation including the composite-insulin sensitivity index (composite ISI).
- Serum RBP4 measurement using competitive enzyme-linked immunosorbent assay (ELISA).
- Multivariate logistic regression analysis to identify factors associated with RBP4 levels.
Main Results:
- Serum RBP4 levels were similar between LBW and term AGA groups.
- LBW women exhibited significantly lower composite ISI, indicating IR.
- Hormonal contraception (HC) use, but not birth weight or parental diabetes, was significantly associated with higher RBP4 levels (OR = 10.6).
- Women using HC had higher RBP4, triglycerides, cholesterol, CRP, and SHBG, but similar composite ISI compared to non-users.
Conclusions:
- Serum RBP4 is not a reliable marker for early insulin resistance in LBW young women.
- Hormonal contraception use is associated with sustained increases in serum RBP4 levels.
- The clinical and pathophysiological significance of elevated RBP4 under HC warrants further investigation.
Abstract:
It has been recently reported that increased serum levels of retinol binding protein 4 (RBP4), a molecule secreted by adipocytes and liver, could be an early marker of insulin resistance (IR). We determined whether serum RBP4 was increased in low birth weight (LBW)-young women as a model of early-onset IR, through a historical prospective study. The study-population included 35 LBW and 35 born at term appropriate for gestational age (term AGA) young women. Metabolic evaluations included the composite-insulin sensitivity index (composite ISI). Serum RBP4 was measured with a competitive enzyme-linked immunosorbent assay (ELISA). RBP4 levels were similar in LBW and term AGA women, while composite ISI was significantly lower in the former group. With multivariate logistic regression analysis hormonal contraception (HC) use but not birth weight, diabetes in either parents and body mass index was significantly associated with higher RBP4 levels: odds ratio = 10.6; 95% confidence interval (CI) = 2.4-76.6. In spite of higher RBP4 levels in women under HC, composite ISI was similar in women with or without HC. Women under HC also exhibited significantly higher levels of sex hormone binding globulin (SHBG), triglycerides, cholesterol, and C-reactive protein (CRP), and all of them, but not composite ISI, were significantly correlated with RBP4 levels. In conclusion, RBP4 serum level was not a marker of IR but, for the first time, it is documented a sustained increase of serum RBP4 under HC. Pathophysiological and clinical significance of this novel finding requires further investigations.
More Related Videos
08:18Methodology for Studying Interactions of Vitamin A Membrane Receptors and Opsin Protein with their Ligands in Generating the Retinylidene Protein
Published on: October 4, 2024
05:03Quantitative Analysis of Dietary Vitamin A Metabolites in Murine Ocular and Non-Ocular Tissues Using High-Performance Liquid Chromatography
Published on: December 27, 2024
Related Concept Videos
Acne Infection
Insulin: The Receptor and Signaling Pathways
Factors Affecting Protein-Drug Binding: Patient-Related Factors
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
Diabetic Retinopathy
Type II Diabetes I: Introduction
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...